Definition/General

Introduction:
-Juvenile polyps are hamartomatous polyps characterized by cystically dilated glands and inflammatory stroma
-They are benign lesions most common in children
-They show normal epithelium without dysplasia
-They can be sporadic or part of juvenile polyposis syndrome.
Origin:
-Results from hamartomatous proliferation
-Inflammatory response leads to stromal expansion
-Cystic glandular dilatation develops
-Surface ulceration common due to trauma
-SMAD4 or BMPR1A mutations in syndromic cases.
Classification:
-Sporadic juvenile polyps: isolated lesions
-Juvenile polyposis syndrome: multiple polyps
-Infantile type: smooth surface
-Adult type: lobulated surface
-Based on location: colonic (90%), small bowel (10%).
Epidemiology:
-Most common polyp in children
-Peak incidence: 2-10 years
-Slight male predominance
-Rectosigmoid most common location
-Small bowel involvement rare (5-10% cases).

Clinical Features

Presentation:
-Rectal bleeding (most common)
-Polyp prolapse through rectum
-Abdominal pain
-Intussusception (small bowel polyps)
-Iron deficiency anemia
-Usually asymptomatic (small polyps).
Symptoms:
-Painless rectal bleeding
-Mucus discharge
-Tenesmus
-Change in bowel habits
-Abdominal cramping
-Prolapsing mass (large polyps).
Risk Factors:
-Young age (childhood)
-Family history (juvenile polyposis syndrome)
-SMAD4 mutations
-BMPR1A mutations
-ENG mutations (hereditary hemorrhagic telangiectasia overlap).
Screening:
-Colonoscopy (if symptomatic)
-Genetic testing (multiple polyps)
-Family screening (syndromic cases)
-Upper endoscopy (small bowel polyps)
-Capsule endoscopy.

Master Juvenile Polyp Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Pedunculated polyps with smooth surface
-Cherry-red coloration
-Soft, friable consistency
-Surface ulceration common
-Lobulated contour
-Size varies (0.5-3 cm).
Characteristics:
-Rounded, smooth surface
-Pedunculated attachment
-Granular appearance
-Hemorrhagic surface
-Easily traumatized
-Non-neoplastic appearance.
Size Location:
-Small bowel involvement uncommon
-Duodenum occasionally
-Jejunum and ileum rare
-Size: 0.5-3 cm typically
-Usually solitary in small bowel.
Multifocality:
-Solitary polyps (sporadic cases)
-Multiple polyps (juvenile polyposis syndrome)
-Concurrent colonic polyps common
-Gastric polyps in syndromic cases.

Microscopic Description

Histological Features:
-Cystically dilated glands filled with mucin
-Inflamed fibrous stroma
-Surface epithelial ulceration
-Chronic inflammation
-Granulation tissue
-Normal epithelium (no dysplasia).
Cellular Characteristics:
-Normal columnar epithelium
-Goblet cells preserved
-Inflammatory cells: lymphocytes, plasma cells, eosinophils
-Fibroblasts and endothelial cells
-Smooth muscle fibers (minimal).
Architectural Patterns:
-Cystic glandular dilatation
-Branching gland pattern
-Stromal expansion with inflammation
-Surface erosion and ulceration
-Edematous stroma
-Vascular congestion.
Grading Criteria:
-No grading system (benign hamartomas)
-Surface ulceration assessment
-Degree of inflammation
-Epithelial regeneration
-Presence of dysplasia (rare, suggests malignant transformation).

Immunohistochemistry

Positive Markers:
-CK20 (surface epithelium)
-CDX2 (intestinal differentiation)
-MUC2 (goblet cells)
-Ki-67 (low proliferation)
-Smooth muscle actin (stromal smooth muscle).
Negative Markers:
-p53 (usually negative)
-β-catenin (membranous pattern)
-MLH1, MSH2 (retained expression)
-Chromogranin A (no neuroendocrine cells).
Diagnostic Utility:
-Confirms intestinal epithelial origin
-Demonstrates lack of dysplasia
-Excludes adenomatous polyps
-Assesses proliferative activity
-Evaluates mismatch repair proteins (syndromic cases).
Molecular Subtypes:
-Sporadic juvenile polyps: normal markers
-Juvenile polyposis syndrome: SMAD4/BMPR1A loss
-HHT-JPS overlap: ENG mutations.

Molecular/Genetic

Genetic Mutations:
-SMAD4 mutations (50-60% of JPS)
-BMPR1A mutations (20-25% of JPS)
-ENG mutations (rare, HHT overlap)
-PTEN mutations (PTEN hamartoma syndrome)
-10q23 deletions.
Molecular Markers:
-TGF-β pathway disruption
-BMP signaling abnormalities
-Loss of growth suppression
-PTEN/PI3K pathway (some cases)
-Angiogenesis factors.
Prognostic Significance:
-Sporadic polyps: excellent prognosis
-Juvenile polyposis syndrome: increased cancer risk (50% lifetime risk)
-Early onset: higher cancer risk
-Family history: genetic counseling needed.
Therapeutic Targets:
-Polypectomy: curative for sporadic polyps
-Surveillance endoscopy: syndromic cases
-Prophylactic surgery: extensive polyposis
-Genetic counseling
-Family screening.

Differential Diagnosis

Similar Entities:
-Peutz-Jeghers polyp
-Inflammatory polyp
-Adenomatous polyp
-Hyperplastic polyp
-Inflammatory bowel disease polyp
-Retention polyp.
Distinguishing Features:
-Juvenile polyp: cystic glands, inflammatory stroma
-PJ polyp: smooth muscle core
-Adenoma: dysplastic epithelium
-Hyperplastic: serrated architecture
-IBD polyp: background colitis.
Diagnostic Challenges:
-Distinguishing from inflammatory polyps
-Recognizing syndromic cases
-Excluding dysplastic changes
-Identifying surface ulceration
-Correlation with clinical presentation.
Rare Variants:
-Atypical juvenile polyps
-Juvenile polyps with dysplasia
-Mixed hamartomatous polyps
-Giant juvenile polyps
-Juvenile polyposis coli.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Small bowel polyp, [size] cm, [pedunculated/sessile]

Diagnosis

Juvenile (hamartomatous) polyp

Histological Features

Hamartomatous polyp with cystic glandular dilatation and inflammatory stroma

Glandular Features

Cystically dilated glands filled with mucin and lined by normal epithelium

Stromal Features

Inflamed fibrous stroma with chronic inflammatory infiltrate

Epithelial Changes

Surface epithelium shows [intact/ulcerated] with no dysplasia

Dysplasia

No dysplastic changes identified

Special Studies

CDX2: positive (intestinal epithelium), Ki-67: low proliferation index

Genetic testing: [recommended if multiple polyps]

[other study]: [result]

Recommendations

Clinical correlation, consider genetic evaluation if multiple polyps or family history

Final Diagnosis

Small intestinal juvenile (hamartomatous) polyp without dysplasia